Infective endocarditis of the aortic valve in an 85-year-old man due to translocation of the intestinal flora

Infective endocarditis (IE) is an infectious and inflammatory  disease of the endocardium that is associated with a high incidence of complications  and mortality. Elderly patients are the most vulnerable  age group for the IE. Infective endocarditis caused by E. coli is a rare disease due to both bacteria life-cycle and human immune system protection. Nevertheless, recent years the incidence of IE associated with E. coli has been increasing in the group of elderly patients. It seems important to reassess the indications  for antibiotic prophylaxis  in certain categories of patients (including  the elderly patients with an unobvious but increased risk of IE). This clinical case demonstrates a native valve endocarditis caused by E. coli developed after bowel preparation with osmotic laxatives and endoscopic procedure in an 85 year-old male without significant chronic diseases. Despite the fact that the patient did not belong to the category of increased risk of IE, he had the predisposing  conditions for the development of IE (weaked immune system, bacteremia, heart valve sclerosis), that realized in the active manifest disease. Treatment with antibiotics led to an improvement  in the patient’s condition and regression of infectious vegetations on the valve. Repeat blood cultures were negative. When planning endoscopic procedure for patients at risks (elderly person, weakened immune system, minimal aortic valve lesions), antibacterial prophylaxis should be considered. Additional research is required to develop clear algorithms for antibacterial prophylaxis.

1. Zheng D, Zhou H, Wang H, Zhu Y, Wu Y, Li Q, Li T, Liu L. Mesenchymal stem cell-derived microvesicles improve intestinal barrier function by restoring mitochondrial dynamic balance in sepsis rats. Stem Cell Res Ther. 2021;12(1):299. https://doi.org/10.1186/s13287-021-02363-0.

2. Assimakopoulos SF, Triantos C, Thomopoulos K, Fligou F, Maroulis I, Marangos M, Gogos CA. Gut-origin sepsis in the critically ill patient: pathophysiology and treatment. Infection. 2018;46(6):751–760. https://doi.org/10.1007/s15010-018-1178-5.

3. Vaishnavi C. Translocation of gut flora and its role in sepsis. Indian J Med Microbiol. 2013;31(4):334–342. https://doi.org/10.4103/0255-0857.118870.

4. Podoprigora GI, Kafarskaya LI, Baynov NA, Shkoporov AN. Bacterial Translocation from Intestine: Microbiological, Immunological and Pathophysiological Aspects. Annals of Russian Academy of Medical Sciences. 2015;(6):640–650. (In Russ.) https://doi.org/10.15690/vramn564.

5. Nelson DB. Infectious disease complications of GI endoscopy: part II, exogenous infections. Gastrointest Endosc. 2003;57(6):695–711. https://doi.org/10.1067/mge.2003.202.

6. Khashab MA, Chithadi KV, Acosta RD, Bruining DH, Chandrasekhara V, Eloubeidi MA et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2015;81(1):81–89. https://doi.org/10.1016/j.gie.2014.08.008.

7. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007;147(12):829–835. https://doi.org/10.7326/0003-4819-147-12-200712180-00002.

8. Akuzawa N, Kurabayashi M. Native valve endocarditis due to Escherichia coli infection: a case report and review of the literature. BMC Cardiovasc Disord. 2018;18(1):195. https://doi.org/10.1186/s12872-018-0929-7.

9. Watanakunakorn C, Burkert T. Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes. Medicine (Baltimore). 1993;72(2):90–102. https://doi.org/10.1097/00005792-199303000-00003.

10. Kim CJ, Yi JE, Kim Y, Choi HJ. Emphysematous endocarditis caused by AmpC beta-lactamase-producing Escherichia coli: A case report. Medicine (Baltimore). 2018;97(6):e9620. https://doi.org/10.1097/MD.0000000000009620.

11. Tsutsumi T, Hiraoka E, Kanazawa K, Akita H, Eron LJ. Diagnosis of E. coli tricuspid valve endocarditis: a case report. Hawaii Med J. 2010;69(12):286. Available at: https://pubmed.ncbi.nlm.nih.gov/21225584.

12. Spaleniak S, Romejko-Ciepielewska K, Lubas A, Ryczek R, Niemczyk S. Infective endocarditis in the course of urosepsis E. coli ESBL(+) in a patient with Goodpasture’s syndrome. Kardiol Pol. 2015;73(8):670. https://doi.org/10.5603/KP.2015.0154.

13. Nikolich-Žugich J. Author Correction: The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19(10):1146. https://doi.org/10.1038/s41590-018-0205-0.

14. Tamura J, Kubota K, Murakami H, Sawamura M, Matsushima T, Tamura T, Saitoh T, Kurabayshi H, Naruse T. Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin Exp Immunol. 1999;116(1):28–32. https://doi.org/10.1046/j.1365-2249.1999.00870.x.

15. Yumoto T, Kono Y, Kawano S, Kamoi C, Iida A, Nose M et al. Citrobacter braakii bacteremia-induced septic shock after colonoscopy preparation with polyethylene glycol in a critically ill patient: a case report. Ann Clin Microbiol Antimicrob. 2017;16(1):22. https://doi.org/10.1186/s12941-017-0201-5.

16. Darrow CJ, Devito JF. An occurrence of sepsis during inpatient fecal disimpaction. Pediatrics. 2014;133(1):e235–239. https://doi.org/10.1542/peds.2012-2963.

17. Cullender TC, Chassaing B, Janzon A, Kumar K, Muller CE, Werner JJ et al. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe. 2013;14(5):571–581. https://doi.org/10.1016/j.chom.2013.10.009.

18. Barbara G, Scaioli E, Barbaro MR, Biagi E, Laghi L, Cremon C et al. Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease. Gut. 2017;66(7):1252–1261. https://doi.org/10.1136/gutjnl-2016-312377.

19. Nagata N, Tohya M, Fukuda S, Suda W, Nishijims A, Takeuchi F et al. Effects of bowel preparation on the human gut microbiome and metabolome. Sci Rep. 2019;9(1):4042. https://doi.org/10.1038/s41598-019-40182-9.

20. Drago L, Toscano M, De Grandi R, Casini V, Pace F. Persisting changes of intestinal microbiota after bowel lavage and colonoscopy. Eur J Gastroenterol Hepatol. 2016;28(5):532–537. https://doi.org/10.1097/MEG.0000000000000581.

21. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538–541. https://doi.org/10.1038/nature10554.